6533b830fe1ef96bd129717d

RESEARCH PRODUCT

A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials

Tobias MützeAntje Jahn-eimermacherGerrit Toenges

subject

Statistics and Probabilitymedicine.medical_specialtyEpidemiology610 Medizinheart failureleast false parameterPositive correlationjoint frailty modelCorrelationLWYY model610 Medical sciencesInternal medicineMulticenter trialmedicineHumansTreatment effectFraction (mathematics)proportional rates modelsProportional Hazards ModelsProportional hazards modelbusiness.industry610 Medical sciences; Medicinemedicine.diseasecomposite endpointRecurrent eventTreatment Outcomeddc: 610recurrent eventsHeart failureCardiologybusiness

description

In heart failure trials efficacy is usually proven by a composite endpoint including cardiovascular death (CVD) and recurrent heart failure hospitalisations (HFH), evaluated with time-to-first-event analysis based on a Cox model. As a considerable fraction of events is ignored that way, recurrent event[for full text, please go to the a.m. URL]

https://dx.doi.org/10.3205/20gmds033